McAllen’s 3-1-1 Operating Daily

Translate to Spanish or other 102 languages!

Monday-Sunday, 8:00 a.m.– 6:00 p.m.

Mega Doctor News

- Advertisement -

Earlier today, the City of McAllen announced that residents and visitors can now contact its 3-1-1 Customer Service Call Center daily, as the service is now available Monday through Sunday, 8:00 a.m. – 6:00 p.m. until further notice.



“We understand that our residents and visitors to our community have many questions, especially relating to details of the emergency order, services offered by community agencies, or information on modified McAllen city services,” said McAllen City Manager Roel “Roy” Rodriguez, P.E.  “These questions do not just arise during the regular work week and some people really do just prefer to speak to a live customer service representative, to get the answers they need.  We hope that this extended operation of service will help provide everyone with the information they are seeking.”

Anyone in the McAllen area can simply call 3-1-1 – those outside McAllen city limits please dial 681-3111 – to report concerns, request information on various city and community services and so much more. 

- Advertisement -

“You’ll speak to a customer-service friendly live agent who can help you answer all kinds of City of McAllen questions, in either English or Spanish.  3-1-1 is making life easier for all McAllen residents and visitors,” said Marco Tovias, McAllen 3-1-1 Customer Service Coordinator.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

STHS Children’s Marks 20th Anniversary with Gala Honoring Pediatric Providers Behind Its Success

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.
- Advertisement -